We're continuing to strengthen our high-throughput screening capabilities with the addition of another Qube automated patch clamp system to our laboratory, providing clients with greater capacity and flexibility to support their ion channel drug discovery programmes.
For our clients, this increased capacity means greater access to high-throughput electrophysiology screening, helping to keep projects progressing efficiently while maintaining the high standards of data quality and scientific expertise they expect from Metrion.
As Gary Clark, PhD, Director of Ion Channel Screening, explains: "The addition of another Qube is an important step for our laboratory. It increases our capacity and enables us to support our growing number of high-throughput screening projects for our clients."
As demand for high-throughput screening continues to grow, this investment reinforces our commitment to providing clients with the specialist electrophysiology expertise, advanced technologies and reliable data they need to make informed drug discovery decisions.
We're continuing to strengthen our high-throughput screening capabilities with the addition of another Qube automated patch clamp system to our laboratory, providing clients with greater capacity and flexibility to support their ion channel drug discovery programmes.
For our clients, this increased capacity means greater access to high-throughput electrophysiology screening, helping to keep projects progressing efficiently while maintaining the high standards of data quality and scientific expertise they expect from Metrion.
As Gary Clark, PhD, Director of Ion Channel Screening, explains: "The addition of another Qube is an important step for our laboratory. It increases our capacity and enables us to support our growing number of high-throughput screening projects for our clients."
As demand for high-throughput screening continues to grow, this investment reinforces our commitment to providing clients with the specialist electrophysiology expertise, advanced technologies and reliable data they need to make informed drug discovery decisions.
We're continuing to strengthen our high-throughput screening capabilities with the addition of another Qube automated patch clamp system to our laboratory, providing clients with greater capacity and flexibility to support their ion channel drug discovery programmes.
For our clients, this increased capacity means greater access to high-throughput electrophysiology screening, helping to keep projects progressing efficiently while maintaining the high standards of data quality and scientific expertise they expect from Metrion.
As Gary Clark, PhD, Director of Ion Channel Screening, explains: "The addition of another Qube is an important step for our laboratory. It increases our capacity and enables us to support our growing number of high-throughput screening projects for our clients."
As demand for high-throughput screening continues to grow, this investment reinforces our commitment to providing clients with the specialist electrophysiology expertise, advanced technologies and reliable data they need to make informed drug discovery decisions.